Stay updated on Pembrolizumab Combo in 1L NSCLC Maintenance Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in 1L NSCLC Maintenance Clinical Trial page.

Latest updates to the Pembrolizumab Combo in 1L NSCLC Maintenance Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe page now shows Revision: v3.3.3, and the HHS Vulnerability Disclosure link along with the older Revision: v3.3.2 entry were removed.SummaryDifference0.1%

- Check26 days agoNo Change Detected
- Check41 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.3.1 was removed from the page history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check48 days agoChange DetectedRevision history now includes Revision: v3.3.1 and no longer lists Revision: v3.2.0.SummaryDifference0.0%

- Check55 days agoChange DetectedRemoved the government funding lapse notice banner from the page; the record history data and page functionality remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check69 days agoChange DetectedUpdates appear limited to the history/version list UI with no core study changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check77 days agoChange DetectedVersion 93 (2025-10-22) adds the Study Status entry in the record history. This update reflects changes in the trial's current operational state.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab Combo in 1L NSCLC Maintenance Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in 1L NSCLC Maintenance Clinical Trial page.